Skip to main navigation Skip to search Skip to main content

58-week open-label trial of Tavapadon in Parkinson’s Disease (tempo-4 trial)

  • Haddy, Jessica (Primary Chief Investigator (PCI))
  • Iansek, Robert (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date19/05/2118/05/26

Keywords

  • clinical trial
  • Parkinson's disease
  • treatment efficacy
  • treatment safety